Endocannabinoids in striatal plasticity

scientific article published on January 2012

Endocannabinoids in striatal plasticity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1353-8020(11)70041-4
P932PMC publication ID4791581
P698PubMed publication ID22166411

P2093author name stringBrian N Mathur
David M Lovinger
P2860cites workCoactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatumQ48446136
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old miceQ27324171
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neuronsQ29615480
Dichotomous dopaminergic control of striatal synaptic plasticityQ30493521
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivityQ34487550
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.Q34521936
Dopamine-mediated regulation of corticostriatal synaptic plasticity.Q36762821
Presynaptic modulation by endocannabinoidsQ37026723
The endocannabinoid system as a target for the treatment of motor dysfunctionQ37394164
Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatumQ37680104
Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugsQ37694608
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia.Q39801798
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patientsQ42167232
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease modelsQ42508054
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.Q44102387
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivoQ44641132
Mechanisms for synapse specificity during striatal long-term depression.Q45937925
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum.Q46279749
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease.Q48114419
P921main subjectstriatumQ1319792
endocannabinoidsQ10483908
P304page(s)S132-4
P577publication date2012-01-01
P1433published inParkinsonism and Related DisordersQ15762600
P1476titleEndocannabinoids in striatal plasticity
P478volume18 Suppl 1

Reverse relations

cites work (P2860)
Q47643855CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana.
Q42493834Calcium dynamics predict direction of synaptic plasticity in striatal spiny projection neurons
Q38522769Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia
Q98288614Cannabinoids, Endocannabinoids and Sleep
Q36768205Closing the gate in the limbic striatum: prefrontal suppression of hippocampal and thalamic inputs.
Q38992136Deep brain stimulation of the subthalamic nucleus preferentially alters the translational profile of striatopallidal neurons in an animal model of Parkinson's disease
Q33583792Endocannabinoids and striatal function: implications for addiction-related behaviours
Q26851389Modeling intracellular signaling underlying striatal function in health and disease
Q34614351Presynaptic long-term depression mediated by Gi/o-coupled receptors.
Q39381131Synaptic functions of endocannabinoid signaling in health and disease
Q48058857Using In Vitro Electrophysiology to Screen Medications: Accumbal Plasticity as an Engram of Alcohol Dependence.
Q38428721Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy
Q92878129Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons

Search more.